z-logo
open-access-imgOpen Access
Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis
Author(s) -
G Tonel,
Curdin Conrad,
Ute Laggner,
Paola Di Meglio,
Katarzyna Grys,
Terrill K. McClanahan,
Wendy M. Blumenschein,
JianZhong Qin,
Xin Hong,
Elizabeth R. Oldham,
Robert Kastelein,
Brian J. Nickoloff,
Frank O. Nestlé
Publication year - 2010
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1001538
Subject(s) - psoriasis , immunology , medicine , disease , cytokine , interleukin , interleukin 23 , receptor , monoclonal antibody , tumor necrosis factor alpha , interleukin 17 , effector , antibody
Interleukin-23 is a key cytokine involved in the generation of Th17 effector cells. Clinical efficacy of an anti-p40 mAb blocking both IL-12 and IL-23 and disease association with single nucleotide polymorphisms in the IL23R gene raise the question of a functional role of IL-23 in psoriasis. In this study, we provide a comprehensive analysis of IL-23 and its receptor in psoriasis and demonstrate its functional importance in a disease-relevant model system. The expression of IL-23 and its receptor was increased in the tissues of patients with psoriasis. Injection of a mAb specifically neutralizing human IL-23 showed IL-23-dependent inhibition of psoriasis development comparable to the use of anti-TNF blockers in a clinically relevant xenotransplant mouse model of psoriasis. Together, our results identify a critical functional role for IL-23 in psoriasis and provide the rationale for new treatment strategies in chronic epithelial inflammatory disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom